Axitinib with or without dose titration as first-line therapy for metastatic renal cell carcinoma (mRCC)

被引：0
|
作者：
Jonasch, E.
Bair, A.
Chen, Y.
Rini, B. I.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Pfizer Oncol, San Diego, CA USA
[3] Cleveland Clin, Cleveland, OH 44106 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.tps235
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS235
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Axitinib with or without dose titration for first-line metastatic renal cell carcinoma (mRCC): Unblinded results from a randomized phase II study
    Rini, Brian I.
    Gruenwald, Viktor
    Fishman, Mayer N.
    Melichar, Bohuslav
    Ueda, Takeshi
    Bair, A. H.
    Chen, Ying
    Bycott, Paul W.
    Pavlov, Dmitri
    Kim, Sinil
    Jonasch, Eric
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [2] Axitinib versus sorafenib as first-line therapy in patients with metastatic renal cell carcinoma (mRCC)
    Hutson, Thomas E.
    Gallardo, Jorge
    Lesovoy, Vladmir
    Al-Shukri, Salman
    Stus, Viktor
    Bair, A. H.
    Rosbrook, Brad
    Bycott, Paul W.
    Tarazi, Jamal Christo
    Kim, Sinil
    Vogelzang, Nicholas J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [3] Randomised phase II trial of axitinib with or without dose titration in first-line metastatic renal cell carcinoma (mRCC): Efficacy and pharmacokinetic (PK) analyses
    Rini, B. I.
    Melichar, B.
    Ueda, T.
    Fishman, M. N.
    Pithavala, Y.
    Chen, Y.
    Andrews, G.
    Bair, A. H.
    Kim, S.
    Grunwald, V.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S657 - S657
  • [4] Axitinib as first-line therapy in metastatic renal cell carcinoma
    Nozawa, Masahiro
    Uemura, Hirotsugu
    [J]. TRANSLATIONAL CANCER RESEARCH, 2014, 3 (06) : 555 - 557
  • [5] Phase III AXIS trial for second-line metastatic renal cell carcinoma (mRCC): Effect of prior first-line treatment duration and axitinib dose titration on axitinib efficacy.
    Rini, Brian I.
    Escudier, Bernard J.
    Michaelson, M. Dror
    Negrier, Sylvie
    Gore, Martin Eric
    Oudard, Stephane
    Clark, Joseph
    Tarazi, Jamal Christo
    Rosbrook, Brad
    Kim, Sinil
    Motzer, Robert John
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [6] Overall Survival Analysis From a Randomized Phase II Study of Axitinib With or Without Dose Titration in First-Line Metastatic Renal Cell Carcinoma
    Rini, Brian I.
    Tomita, Yoshihiko
    Melichar, Bohuslav
    Ueda, Takeshi
    Gruenwald, Viktor
    Fishman, Mayer N.
    Uemura, Hirotsugu
    Oya, Mototsugu
    Bair, Angel H.
    Andrews, Glen I.
    Rosbrook, Brad
    Jonaschl, Eric
    [J]. CLINICAL GENITOURINARY CANCER, 2016, 14 (06) : 499 - 503
  • [7] Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial
    Rini, Brian I.
    Melichar, Bohuslav
    Ueda, Takeshi
    Gruenwald, Viktor
    Fishman, Mayer N.
    Arranz, Jose A.
    Bair, Angel H.
    Pithavala, Yazdi K.
    Andrews, Glen I.
    Pavlov, Dmitri
    Kim, Sinil
    Jonasch, Eric
    [J]. LANCET ONCOLOGY, 2013, 14 (12): : 1233 - 1242
  • [8] Overall survival analysis from a randomized phase II study of axitinib with or without dose titration for first-line metastatic renal cell carcinoma.
    Rini, Brian I.
    Tomita, Yoshihiko
    Melichar, Bohuslav
    Ueda, Takeshi
    Gruenwald, Viktor
    Fishman, Mayer N.
    Uemura, Hirotsugu
    Oya, Mototsugu
    Bair, A. H.
    Andrews, Glen
    Pavlov, Dmitri
    Jonasch, Eric
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] The efficacy of axitinib as a first-line treatment for metastatic renal cell carcinoma
    Kameda, Tomohiro
    Takayama, Tatsuya
    Sugihara, Toru
    Takeshima, Saki
    Yamazaki, Masahiro
    Komatsubara, Maiko
    Kamei, Jun
    Fujisaki, Akira
    Ando, Satoshi
    Kurokawa, Shinsuke
    Fujimura, Tetsuya
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 (04) : 241 - 246
  • [10] First-line axitinib therapy is less effective in metastatic renal cell carcinoma with spindle histology
    Kazuyuki Numakura
    Mizuki Kobayashi
    Yumina Muto
    Yuya Sekine
    Makoto Takahashi
    Soki Kashima
    Ryohei Yamamoto
    Atsushi Koizumi
    Taketoshi Nara
    Mitsuru Saito
    Shintaro Narita
    Hiroshi Nanjyo
    Tomonori Habuchi
    [J]. Scientific Reports, 10
12345